Exploring RCT, RWE and alternative study designs as a path forward
Scott Swain
Advertisement
Articles by Scott Swain
Advertisement
Latest Updated Articles
Getting to answers about Biogen’s AduhelmJuly 7th 2021
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How an FTZ Builds More Flexibility Into Pharmaceutical Inventory Strategy
2
Q&A: Kerem Tokel on Pharma Cargo Theft Hotspots and the Shift to Outbound Diversion
3
What DOL’s Final PBM Rule Means for Rebates and Formularies
4
Why the Best Drug Launches Are Built to Adapt
5